Results 181 to 190 of about 352,273 (289)

Understanding Inequality Within a Personalised System of Disability Support: Australian Children With Disabilities' Unmet Support Needs

Australian Journal of Social Issues, EarlyView.
ABSTRACT Disability support has shifted towards models of personalised care, which critics argue may contribute to increased inequalities. There is limited systematic evidence investigating inequalities in support among children with disabilities. To investigate inequalities in support, a survey of parents of children with disabilities aged 2–17 was ...
Martin O'Flaherty, Jessica Hill, Jennifer Smith‐Merry   +2 more
wiley   +1 more source

Adults With Intellectual Disability Moving out of the Family Home Using the National Disability Insurance Scheme: Family Members' Planning Experiences

Australian Journal of Social Issues, EarlyView.
ABSTRACT For adults with intellectual disability and their families, future planning and moving out of the family home in Australia will increasingly occur within the context of the National Disability Insurance Scheme (NDIS). As a market‐based, individualised funding system its impact on this transition remains largely unknown. This paper reports on a
I. Belperio, R. Walker, C. Bigby, I. Wiesel, F. Rillotta, C. Hutchinson   +5 more
wiley   +1 more source

Phosphorylated Toll-like receptor 3 nuclear translocation in cancer cell promotes metastasis and chemoresistance. [PDF]

Signal Transduct Target Ther
Wang Z, Gu Y, Liu Y, Wang Z, Chen X, Wang H, Zhang W, Jin G, Cao X.   +8 more
europepmc   +1 more source

COVID-19 and hypertension: Is there a role for dsRNA and activation of Toll-like receptor 3? [PDF]

Vascul Pharmacol, 2021
Dela Justina V, Giachini FR, Priviero F, Webb RC.   +3 more
europepmc   +1 more source

Barriers and Enablers for Effective Support Coordination in the National Disability Insurance Scheme

Australian Journal of Social Issues, EarlyView.
ABSTRACT Support coordinators act as intermediaries between the National Disability Insurance Scheme (NDIS) and participants, facilitating access to funded supports. To optimise outcomes, they must navigate NDIS complexities, identify services that meet individual needs and engage with diverse stakeholders.
Sharyn McDonald, Lee Cubis, Di Winkler, Jacinta Douglas   +3 more
wiley   +1 more source

A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol^® in Patients with Recurrent Platinum-Resistant Ovarian Cancer. [PDF]

Curr Oncol
Holloway RW, Temkin SM, Gordon SW, Gupta S, Jada SR, Ahmad S, McGuire WP.   +6 more
europepmc   +1 more source

Toll-Like Receptor 3 (TLR3) Is Engaged in the Intracellular Survival of the Protozoan Parasite <i>Leishmania (Leishmania) amazonensis</i>. [PDF]

Infect Immun, 2022
Rath CT, Vivarini ÁC, Dos Santos JV, Medina JM, Saliba AM, Mottram JC, Lima APCA, Calegari-Silva TC, Pereira RM, Lopes UG.   +9 more
europepmc   +1 more source

Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps

International Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is managed after sinus surgery with topical corticosteroids. Given limited distribution of nasal steroid sprays, patients have the option of either steroid nasal irrigation (SNI) or exhalation delivery system with fluticasone (EDS‐FLU).
Daniel Xiao, Martin J. Citardi, William C. Yao, Amber U. Luong   +3 more
wiley   +1 more source

Late-Stage Activation of Toll-like receptor 3 Alleviates Cognitive Impairment and Neuropathology in an Alzheimer's Disease Mouse Model. [PDF]

Mol Neurobiol
Zhu T, Shen F, Jia X, Zhou H, Ni W, Wang S, Wu D, Gao H, Shang Z, Zhou Y, Han J, Jin G, Dong F, Zu J, Yang X, Shi H, Zhou C, Hua F.   +17 more
europepmc   +1 more source

The role of mediator suppressor of cytokine signaling (SOCS), toll-like receptor 3 (TLR-3) and nuclear factor kappa B (NFκB) on cytokine production during dengue virus infection. [PDF]

Narra J, 2023
Masyeni S, Kuntaman K, Aryati A, Sofro MA, Hadi U, Mastutik G, Purnomo W, Santosa A, Iqhrammullah M, Yohan B, Nelwan EJ, Sasmono RT.   +11 more
europepmc   +1 more source